Ningbo David (China) Performance
300314 Stock | 12.62 0.28 2.27% |
On a scale of 0 to 100, Ningbo David holds a performance score of 9. The company secures a Beta (Market Risk) of -0.78, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Ningbo David are expected to decrease at a much lower rate. During the bear market, Ningbo David is likely to outperform the market. Please check Ningbo David's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Ningbo David's current price movements will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo David Medical are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo David sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0143 | Payout Ratio 0.5882 | Last Split Factor 18:10 | Forward Dividend Rate 0.18 | Ex Dividend Date 2024-06-19 |
1 | Earnings Tell The Story For Ningbo David Medical Device Co., Ltd. As Its Stock Soars 28 percent - Simply Wall St | 09/27/2024 |
Begin Period Cash Flow | 389.9 M |
Ningbo |
Ningbo David Relative Risk vs. Return Landscape
If you would invest 985.00 in Ningbo David Medical on September 1, 2024 and sell it today you would earn a total of 277.00 from holding Ningbo David Medical or generate 28.12% return on investment over 90 days. Ningbo David Medical is generating 0.5233% of daily returns and assumes 4.3677% volatility on return distribution over the 90 days horizon. Simply put, 38% of stocks are less volatile than Ningbo, and 90% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Ningbo David Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ningbo David's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ningbo David Medical, and traders can use it to determine the average amount a Ningbo David's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1198
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | 300314 | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
4.37 actual daily | 38 62% of assets are more volatile |
Expected Return
0.52 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Ningbo David is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ningbo David by adding it to a well-diversified portfolio.
Ningbo David Fundamentals Growth
Ningbo Stock prices reflect investors' perceptions of the future prospects and financial health of Ningbo David, and Ningbo David fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ningbo Stock performance.
Return On Equity | 0.0762 | ||||
Return On Asset | 0.038 | ||||
Profit Margin | 0.16 % | ||||
Operating Margin | 0.17 % | ||||
Current Valuation | 3.02 B | ||||
Shares Outstanding | 288 M | ||||
Price To Book | 3.09 X | ||||
Price To Sales | 6.46 X | ||||
Revenue | 618.3 M | ||||
Gross Profit | 288.88 M | ||||
EBITDA | 103.68 M | ||||
Net Income | 147.61 M | ||||
Total Debt | 210.61 M | ||||
Book Value Per Share | 4.08 X | ||||
Cash Flow From Operations | 135.2 M | ||||
Earnings Per Share | 0.30 X | ||||
Total Asset | 1.37 B | ||||
Retained Earnings | 613.11 M | ||||
About Ningbo David Performance
By analyzing Ningbo David's fundamental ratios, stakeholders can gain valuable insights into Ningbo David's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ningbo David has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ningbo David has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ningbo David is entity of China. It is traded as Stock on SHE exchange.Things to note about Ningbo David Medical performance evaluation
Checking the ongoing alerts about Ningbo David for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ningbo David Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Ningbo David Medical appears to be risky and price may revert if volatility continues | |
About 69.0% of the company shares are owned by insiders or employees |
- Analyzing Ningbo David's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ningbo David's stock is overvalued or undervalued compared to its peers.
- Examining Ningbo David's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ningbo David's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ningbo David's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ningbo David's stock. These opinions can provide insight into Ningbo David's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ningbo Stock analysis
When running Ningbo David's price analysis, check to measure Ningbo David's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ningbo David is operating at the current time. Most of Ningbo David's value examination focuses on studying past and present price action to predict the probability of Ningbo David's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ningbo David's price. Additionally, you may evaluate how the addition of Ningbo David to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |